These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3013924)

  • 1. Chediak-Higashi syndrome: immunological responses to Epstein-Barr virus studies in gene heterozygotes.
    Merino F; Amesty C; Henle W; Layrisse Z; Bianco N; Ramírez-Duque P
    J Clin Immunol; 1986 May; 6(3):242-8. PubMed ID: 3013924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
    Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
    Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
    Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome.
    Merino F; Henle W; Ramírez-Duque P
    J Clin Immunol; 1986 Jul; 6(4):299-305. PubMed ID: 3018035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
    Katz P; Zaytoun AM; Lee JH; Fauci AS
    J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
    [No Abstract]   [Full Text] [Related]  

  • 6. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome?
    Rubin CM; Burke BA; McKenna RW; McClain KL; White JG; Nesbit ME; Filipovich AH
    Cancer; 1985 Aug; 56(3):524-30. PubMed ID: 2988747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Epstein-Barr virus memory T-cell response in Chediak-Higashi syndrome patients.
    Merino F; Pauza M; Purtilo DT
    Immunol Lett; 1986 Jan; 12(1):51-4. PubMed ID: 3007338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
    Nair MP; Gray RH; Boxer LA; Schwartz SA
    Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological markers for Epstein-Barr virus infection in chronic carriers of hepatitis B surface antigen who live in northern Canada.
    Minuk GY; Sekla LH; Nicolle LE
    J Infect Dis; 1987 Jul; 156(1):202-4. PubMed ID: 3036958
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte subsets in Chediak-Higashi patients.
    Merino F; Lipscomb H; Amesty C; Purtilo D; Ramírez-Duque P
    Immunol Lett; 1983 Feb; 6(2):81-5. PubMed ID: 6221995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2-induced cytotoxicity of Chediak-Higashi lymphocytes.
    Holcombe RF
    Acta Haematol; 1992; 87(1-2):45-8. PubMed ID: 1533985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes.
    Martín-Fernández JM; Cabanillas JA; Rivero-Carmena M; Lacasa E; Pardo J; Anel A; Ramírez-Duque PR; Merino F; Rodríguez-Gallego C; Regueiro JR
    J Leukoc Biol; 2005 May; 77(5):661-8. PubMed ID: 15728247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered lectin-mediated cytotoxicity in Chédiak-Higashi syndrome patients.
    Merino F; Rodríguez F; Biondo-Bracho M; Amesty C; Ramírez-Duque P
    Clin Immunol Immunopathol; 1984 Nov; 33(2):139-43. PubMed ID: 6333304
    [No Abstract]   [Full Text] [Related]  

  • 15. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection.
    Joncas J; Monczak Y; Ghibu F; Alfieri C; Bonin A; Ahronheim G; Rivard G
    J Med Virol; 1989 Jun; 28(2):110-7. PubMed ID: 2544675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitivity but normal DNA-repair activity after UV irradiation in Epstein--Barr virus-transformed lymphoblastoid cell lines from Chediak--Higashi syndrome.
    Tanaka H; Orii T
    Mutat Res; 1980 Aug; 72(1):143-50. PubMed ID: 6255323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between natural cytotoxicity activity, Epstein-Barr virus (EBV) antibody titer and clinical status in nasopharyngeal carcinoma patients].
    Mu M
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(1):46-9. PubMed ID: 2856431
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency.
    Pflugfelder SC; Tseng SC; Pepose JS; Fletcher MA; Klimas N; Feuer W
    Ophthalmology; 1990 Mar; 97(3):313-23. PubMed ID: 2159609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic significance of antibodies to the Epstein-Barr virus-specific membrane antigen gp250.
    Jilg W; Wolf H
    J Infect Dis; 1985 Jul; 152(1):222-5. PubMed ID: 2989385
    [No Abstract]   [Full Text] [Related]  

  • 20. Gamma-delta T cells in Chediak-Higashi syndrome.
    Holcombe RF; van de Griend R; Ang SL; Bolhuis RL; Seidman JG
    Acta Haematol; 1990; 83(4):193-7. PubMed ID: 2115716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.